Imodium Akut Lingual (Loperamide Hydrochloride)

Loperamide Hydrochloride is a peripherally acting μ‑opioid receptor agonist that binds to receptors in the intestinal wall. This action decreases the release of acetylcholine and prostaglandins, leading to reduced smooth‑muscle contractions and fluid secretion, which slows bowel movements and firmes stools.

The specific dose of Imodium Akut Lingual is determined by a qualified healthcare professional based on the individual’s condition, severity of symptoms, and response to therapy. Patients should follow the prescriber’s instructions and the product labeling for appropriate use.

Loperamide Hydrochloride is classified as pregnancy category B, indicating no evidence of risk in animal studies and a lack of well‑controlled studies in pregnant women. It may be used during pregnancy or lactation only if the potential benefit justifies the potential risk; consultation with a healthcare provider is essential.

To order Imodium Akut Lingual, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with other antidiarrheals such as bismuth subsalicylate or diphenoxylate‑atropine, Loperamide Hydrochloride provides rapid symptom relief with minimal systemic opioid effects due to its peripheral action. It is generally well‑tolerated, but clinicians consider individual patient factors, drug interactions and the severity of diarrhea when selecting therapy.

Imodium Akut Lingual should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original blister pack or container, protect them from moisture and direct sunlight, and keep out of reach of children.

The lingual tablet is placed on the tongue and allowed to dissolve completely before swallowing. This route provides rapid absorption through the oral mucosa, offering quick onset of action for diarrheal relief.

Serious risks include severe constipation leading to bowel obstruction, paralytic ileus, and rare cardiac arrhythmias, especially when combined with CYP3A4 or P‑glycoprotein inhibitors. Patients should seek immediate medical attention if they experience abdominal pain, bloating, vomiting, or irregular heartbeats.

Imodium Akut Lingual should be avoided in individuals with known hypersensitivity to loperamide, in children under two years of age without medical advice, and in patients with acute dysentery, bacterial enterocolitis, or colitis caused by Clostridioides difficile unless directed by a physician.